317 related articles for article (PubMed ID: 26607410)
1. Testing multiple primary endpoints in clinical trials with sample size adaptation.
Liu Y; Hu M
Pharm Stat; 2016; 15(1):37-45. PubMed ID: 26607410
[TBL] [Abstract][Full Text] [Related]
2. Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.
Jörgens S; Wassmer G; König F; Posch M
Pharm Stat; 2019 May; 18(3):329-350. PubMed ID: 30652401
[TBL] [Abstract][Full Text] [Related]
3. Design and analysis issues of multiregional clinical trials with different regional primary endpoints.
Tsou HH; Tsong Y; Chang WJ; Dong X; Hsiao CF
J Biopharm Stat; 2012 Sep; 22(5):1051-9. PubMed ID: 22946949
[TBL] [Abstract][Full Text] [Related]
4. Power and sample size determination in clinical trials with multiple primary continuous correlated endpoints.
Lafaye de Micheaux P; Liquet B; Marque S; Riou J
J Biopharm Stat; 2014; 24(2):378-97. PubMed ID: 24605975
[TBL] [Abstract][Full Text] [Related]
5. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
[TBL] [Abstract][Full Text] [Related]
6. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
7. Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.
Chen LM; Ibrahim JG; Chu H
J Biopharm Stat; 2014; 24(4):817-33. PubMed ID: 24697500
[TBL] [Abstract][Full Text] [Related]
8. Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables.
Sozu T; Sugimoto T; Hamasaki T
Biom J; 2012 Sep; 54(5):716-29. PubMed ID: 22829198
[TBL] [Abstract][Full Text] [Related]
9. A consistency-adjusted strategy for accommodating an underpowered primary endpoint.
Huque MF; Alosh M
J Biopharm Stat; 2012; 22(1):160-79. PubMed ID: 22204533
[TBL] [Abstract][Full Text] [Related]
10. Adaptive seamless designs with interim treatment selection: a case study in oncology.
Carreras M; Gutjahr G; Brannath W
Stat Med; 2015 Apr; 34(8):1317-33. PubMed ID: 25640198
[TBL] [Abstract][Full Text] [Related]
11. Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.
Hamasaki T; Evans SR; Asakura K
J Biopharm Stat; 2018; 28(1):28-51. PubMed ID: 29083951
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of endpoint shopping on power in confirmatory clinical trials.
Wiens BL
J Biopharm Stat; 2003 May; 13(2):229-40. PubMed ID: 12729391
[TBL] [Abstract][Full Text] [Related]
13. Reducing sample size by combining superiority and non-inferiority for two primary endpoints in the Social Fitness study.
Donkers H; Graff M; Vernooij-Dassen M; Nijhuis-van der Sanden M; Teerenstra S
J Clin Epidemiol; 2017 Jan; 81():86-95. PubMed ID: 27650383
[TBL] [Abstract][Full Text] [Related]
14. Challenge of multiple co-primary endpoints: a new approach.
Chuang-Stein C; Stryszak P; Dmitrienko A; Offen W
Stat Med; 2007 Mar; 26(6):1181-92. PubMed ID: 16927251
[TBL] [Abstract][Full Text] [Related]
15. Novel procedures for validating surrogate endpoints in clinical trials.
Cleophas TJ; Zwinderman AH; Chaib AH
Curr Clin Pharmacol; 2007 May; 2(2):123-8. PubMed ID: 18690859
[TBL] [Abstract][Full Text] [Related]
16. Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial.
Xiong C; Yu K; Gao F; Yan Y; Zhang Z
Clin Trials; 2005; 2(5):387-93. PubMed ID: 16317808
[TBL] [Abstract][Full Text] [Related]
17. Hierarchical testing of multiple endpoints in group-sequential trials.
Glimm E; Maurer W; Bretz F
Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
[TBL] [Abstract][Full Text] [Related]
18. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
19. A group sequential Holm procedure with multiple primary endpoints.
Ye Y; Li A; Liu L; Yao B
Stat Med; 2013 Mar; 32(7):1112-24. PubMed ID: 23239078
[TBL] [Abstract][Full Text] [Related]
20. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
Li H; Wang J; Luo X; Grechko J; Jennison C
Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
